Clinical Trials at Saint Jude Children's Research Hospital
As of August 2026, 26 paid clinical trials are recruiting at Saint Jude Children's Research Hospital, located at St Jude Children's Research Hospital, 262 Danny Thomas Pl, Memphis, TN 38105, phone (901) 595-3300 in Memphis, Tennessee. Active studies at this site cover conditions such as Sickle Cell Disease, Acute Myeloid Leukemia and Neuroblastoma. Compensation typically covers time, travel, and study visits — most studies also offer study-related medical care at no cost to participants.
Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: .
Filter results
26 clinical trials at Saint Jude Children's Research Hospital
·Clear filters·Triptorelin for the Prevention of Ovarian Damage in Adolescents and Young Adults With Cancer
Testing the Addition of an Anti-Cancer Drug, Cabozantinib to the Immunotherapy Drug Cemiplimab (REGN2810), in Adolescents and Adults With Advanced Adrenocortical Cancer
Testing the Addition of the Anti-cancer Drug Venetoclax and/or the Anti-cancer Immunotherapy Blinatumomab to the Usual Chemotherapy Treatment for Infants With Newly Diagnosed KMT2A-rearranged or KMT2A-non-rearranged Leukemia
Project: Every Child for Younger Patients With Cancer
A Study Using Risk Factors to Determine Treatment for Children With Favorable Histology Wilms Tumors (FHWT)
A Study of Combination Chemotherapy for Patients With Newly Diagnosed DAWT and Relapsed FHWT
A Study of the Drug Selinexor With Radiation Therapy in Patients With Newly-Diagnosed Diffuse Intrinsic Pontine (DIPG) Glioma and High-Grade Glioma (HGG)
A Study of the Drugs Selumetinib vs. Carboplatin and Vincristine in Patients With Low-Grade Glioma
A Study Using Nivolumab, in Combination With Chemotherapy Drugs to Treat Nasopharyngeal Carcinoma (NPC)
The Pediatric Acute Leukemia (PedAL) Screening Trial - A Study to Test Bone Marrow and Blood in Children With Leukemia That Has Come Back After Treatment or Is Difficult to Treat - A Leukemia & Lymphoma Society and Children's Oncology Group Study
Thoracotomy Versus Thoracoscopic Management of Pulmonary Metastases in Patients With Osteosarcoma
A Study of Lower Radiotherapy Dose to Treat Children With CNS Germinoma
Dinutuximab With Chemotherapy, Surgery and Stem Cell Transplantation for the Treatment of Children With Newly Diagnosed High Risk Neuroblastoma
Testing the Addition of 131I-MIBG or Lorlatinib to Intensive Therapy in People With High-Risk Neuroblastoma (NBL)
A Study of a New Way to Treat Children and Young Adults With a Brain Tumor Called NGGCT
A Study to Learn More About the Health of Persons With Down Syndrome After Treatment for Acute Leukemia
Testing a Standardized Approach to Surgery and Chemotherapy for Type I Pleuropulmonary Blastoma or the Addition of an Anti-cancer Drug, Topotecan, to the Usual Treatment for Types II and III Pleuropulmonary Blastoma
Trastuzumab Deruxtecan (DS-8201a) for the Treatment of Recurrent or Refractory Osteosarcoma, Wilms Tumor, and Desmoplastic Small Round Cell Tumor
Chemotherapy for the Treatment of Patients With Newly Diagnosed Very Low-Risk and Low Risk Fusion Negative Rhabdomyosarcoma
A Study to Find the Highest Dose of Imetelstat in Combination With Fludarabine and Cytarabine for Patients With AML, MDS or JMML That Has Come Back or Does Not Respond to Therapy
Tegavivint for the Treatment of Recurrent or Refractory Solid Tumors, Including Lymphomas and Desmoid Tumors
A Study to Find the Highest Dose of Cedazuridine and Decitabine Combination With Filgrastim as a Treatment Option After Hematopoietic Stem Cell Transplant in Children With High-Risk Acute Myeloid Leukemia
A Study to Give Treatment Inside the Eye to Treat Retinoblastoma
A Culturally-Tailored Mobile Health and Social Media Physical Activity Intervention for Improving Physical Activity in Hispanic or Latino/Latina Adolescent and Young Adult Childhood Cancer Survivors, Walking Juntos Study
A Study on How to Safely Guide Surgery for Melanoma and Similar Skin Tumors in Children Using Pathology and Genetic Information
Common conditions studied in Memphis
- Sickle Cell Disease (18 active studies)
- Cancer (12 active studies)
- Acute Myeloid Leukemia (9 active studies)
- Neuroblastoma (8 active studies)
- Malignant Solid Neoplasm (7 active studies)
- Acute Lymphoblastic Leukemia (6 active studies)
Leading research sponsors in Memphis
- St. Jude Children's Research Hospital
- National Cancer Institute (NCI)
- Children's Oncology Group
- SWOG Cancer Research Network
- University of Tennessee
Frequently asked questions
How many paid clinical trials are currently recruiting in Memphis?
There are approximately 455 recruiting clinical trials in Memphis, Tennessee listed on ClinicalTrials.gov. The number changes weekly as new studies open and others close enrollment.
Do clinical trials in Memphis pay participants?
Most recruiting trials in Memphis compensate participants for their time, travel, and study visits. Compensation varies by sponsor, study phase, and visit requirements — the exact amount is disclosed by the study team during the informed consent process.
Who can participate in a clinical trial in Memphis?
Eligibility depends on the specific study. Each trial defines its own inclusion criteria (age, diagnosis, medical history, prior treatments) and exclusion criteria. Both patients with specific conditions and healthy volunteers can qualify, depending on the study design.
What conditions are most commonly studied in Memphis?
The most common conditions under active study in Memphis include Sickle Cell Disease (18), Cancer (12), Acute Myeloid Leukemia (9), Neuroblastoma (8), among many others. Browse the list above to explore every recruiting trial.
Are there clinical trials for healthy volunteers in Memphis?
Yes. Healthy-volunteer studies — often early-phase pharmacology or vaccine trials — recruit in Memphis on an ongoing basis. Use the "Healthy volunteers only" filter above to view trials that accept participants without the study's target condition.
How do I enroll in a clinical trial in Memphis?
Click any study title above to see the full study record, including eligibility criteria, visit schedule, and the study team's contact information. Reach out to the central contact or recruiting site directly — they will guide you through screening and informed consent.
Where can I take part in paid clinical trials in Memphis?
Recruiting research sites in Memphis include St. Jude Children's Research Hospital, Baptist Memorial Hospital and Cancer Center-Memphis, Saint Jude Children's Research Hospital, among others. Each site lists its open studies and contact information on the study record above — call or email the site coordinator to ask about screening for a specific protocol.
What kinds of studies are recruiting in Memphis right now?
The largest active categories in Memphis are Cancer & tumors (170), Cardiovascular (25), Neurology & pain (22). Use the filters above to narrow by therapeutic area, phase, age, or healthy-volunteer eligibility.
What is the address of Saint Jude Children's Research Hospital?
Saint Jude Children's Research Hospital is located at St Jude Children's Research Hospital, 262 Danny Thomas Pl, Memphis, TN 38105. Use the Google Maps link in the intro above to get directions.
How do I contact Saint Jude Children's Research Hospital?
You can reach Saint Jude Children's Research Hospital by phone at (901) 595-3300. For questions about a specific trial, use the study coordinator contact listed on the individual study record — click any trial title above to open it.